F. Nava et al., D-2 dopamine receptors enable Delta(9)-tetrahydrocannabinol induced memoryimpairment and reduction of hippocampal extracellular acetylcholine concentration, BR J PHARM, 130(6), 2000, pp. 1201-1210
1 The systemic administration of Delta(9)-tetrahydrocannabinol (2.5-7.5 mg
kg(-1)) reduced hippocampal extracellular acetylcholine concentration and i
mpaired working memory in rats.
2 Both effects were antagonized not only by the CB, cannabinoid receptor an
tagonist SR141716A (0.5 mg kg(-1), i.p.) but also unexpectedly by the D-2 d
opamine receptor antagonist S(-)-sulpiride (5, 10 and 25 mg kg(-1), i.p.).
Conversely, Delta(9)-tetrahydrocannabinol-induced memory impairment and inh
ibition of hippocampal extracellular acetylcholine concentration were poten
tiated by the subcutaneous administration of the D2 dopamine receptor agoni
st (-)-quinpirole (25 and 500 mu g kg(-1)). The inhibition of hippocampal e
xtracellular acetylcholine concentration and working memory produced by the
combination of (-)-quinpirole and Delta(9)-tetrahydrocannabinol was suppre
ssed by either SR141716A or S(-)-sulpiride.
3 Our findings suggest that impairment of working memory and inhibition of
hippocampal extracellular acetylcholine concentration are mediated by the c
oncomitant activation of D-2 dopamine and CB1 cannabinoid receptors, and th
at D-2 dopamine receptor antagonists may be useful in the treatment of the
cognitive deficits induced by marijuana.